Skip to main content

Table 2 Quantitative coronary angiography evaluation at all the four endpoints

From: Polymer-free dual drug-eluting stents evaluated in a porcine model

  

RVD (mm)

P

ER

P

LL (mm)

P

DS%

P

14 day

 

BMS (n = 9)

2.60 ± 0.22

0.061

1.13 ± 0.14

0.067

0.32 ± 0.11

0.655

12.43 ± 4.50

0.429

PrES (n = 10)

2.41 ± 0.31

1.25 ± 0.17

0.43 ± 0.29

19.12 ± 14.87

SES (n = 9)

2.62 ± 0.28

1.17 ± 0.08

0.34 ± 0.21

12.99 ± 7.61

DDES(n = 10)

2.36 ± 0.16

1.27 ± 0.09

0.36 ± 0.18

15.46 ± 8.07

28 day

 

BMS (n = 8)

2.55 ± 0.39

0.994

1.19 ± 0.19

0.946

0.41 ± 0.39

0.409

18.26 ± 20.64

0.365

PrES (n = 8)

2.56 ± 0.31

1.16 ± 0.09

0.28 ± 0.21

10.34 ± 6.93

SES (n = 8)

2.55 ± 0.19

1.18 ± 0.12

0.18 ± 0.15

6.94 ± 5.76

DDES(n = 8)

2.52 ± 0.38

1.20 ± 0.14

0.37 ± 0.32

15.90 ± 15.14

90 day

 

BMS (n = 8)

2.37 ± 0.30

0.945

1.26 ± 0.13

0.662

0.76 ± 0.36

0.767

32.71 ± 16.40

0.809

PrES (n = 8)

2.30 ± 0.22

1.29 ± 0.08

0.85 ± 0.44

37.19 ± 18.71

SES (n = 8)

2.30 ± 0.27

1.29 ± 0.10

0.83 ± 0.34

35.45 ± 15.47

DDES(n = 8)

2.34 ± 0.18

1.24 ± 0.10

0.96 ± 0.35

41.66 ± 15.79

191 day

 

BMS (n = 9)

2.41 ± 0.30

0.335

1.28 ± 0.16

0.368

0.34 ± 0.31

0.079

15.76 ± 16.68

0.811

PrES (n = 9)

2.31 ± 0.29

1.24 ± 0.14

0.62 ± 0.34

27.44 ± 16.22

SES (n = 9)

2.31 ± 0.19

1.30 ± 0.10

0.41 ± 0.25

18.01 ± 11.28

DDES(n = 9)

2.52 ± 0.31

1.19 ± 0.11

0.72 ± 0.36

29.70 ± 15.11

  1. RVD reference vessel diameter, ER expansion ratio, LL lumen loss, DS% diameter stenosis %, BMS Bare-Metal Stents, PrES Probucol-Eluting Stents, SES Sirolimus-Eluting Stents, DDES Dual Drug-Eluting Stents